BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)

SHA:688166 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	17,299	20,740	12,748	14,786	9,535	15,051
Market Cap Growth	36.97%	62.70%	-13.79%	55.07%	-36.65%	-19.85%
Enterprise Value	19,117	22,558	14,391	15,983	10,606	15,560
Last Close Price	40.92	49.06	30.15	34.85	22.36	36.17
PE Ratio	308.59	369.98	67.39	73.03	39.79	61.70
Forward PE	-	28.00	28.00	28.00	28.00	43.06
PS Ratio	14.14	16.95	9.94	12.54	9.37	14.30
PB Ratio	6.83	8.19	5.23	6.12	4.25	8.64
P/TBV Ratio	7.33	8.79	5.54	6.52	4.54	9.47
P/OCF Ratio	-	-	51.91	75.92	30.63	85.48
EV/Sales Ratio	15.62	18.43	11.22	13.55	10.43	14.79
EV/EBITDA Ratio	170.68	201.40	48.52	58.11	39.13	54.92
EV/EBIT Ratio	-	1393.20	71.68	76.75	45.84	62.45
Debt / Equity Ratio	0.93	0.93	0.92	0.91	0.90	0.52
Debt / EBITDA Ratio	20.90	20.90	7.20	7.71	7.17	3.10
Net Debt / Equity Ratio	0.69	0.69	0.60	0.48	0.35	0.32
Net Debt / EBITDA Ratio	15.49	15.49	4.96	4.21	2.92	1.99
Net Debt / FCF Ratio	-	-	-126.33	-5.54	-1.90	-0.77
Asset Turnover	-	-	0.25	0.24	0.27	0.44
Inventory Turnover	-	-	1.58	1.74	1.63	2.33
Quick Ratio	-	-	1.06	1.49	1.92	1.23
Current Ratio	-	-	1.56	2.00	2.39	1.70
Return on Equity (ROE)	2.26%	2.26%	5.82%	7.44%	10.62%	14.97%
Return on Assets (ROA)	-	-	2.46%	2.69%	3.79%	6.49%
Return on Invested Capital (ROIC)	0.38%	0.40%	4.82%	5.79%	7.57%	13.37%
Return on Capital Employed (ROCE)	-	-	4.90%	5.10%	6.00%	10.40%
Earnings Yield	0.32%	0.27%	1.48%	1.37%	2.51%	1.62%
FCF Yield	-	-	-0.09%	-1.41%	-4.36%	-4.87%
Dividend Yield	0.23%	-	0.32%	0.27%	0.51%	0.33%
Payout Ratio	-	-	71.75%	56.80%	41.77%	22.26%
Buyback Yield / Dilution	-2.58%	-2.58%	0.34%	-2.10%	-1.61%	1.87%
Total Shareholder Return	-2.34%	-2.58%	0.66%	-1.82%	-1.10%	2.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.